Reset

Gupta A, Das R, Reed K, Jeon T, Nguyen QTC, Rudra A, Ge X, Trongjit S, Vanrobaeys YS, Langer R, Weissleder R, Garris C, Anderson DG

Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models.
Nat Biotechnol. 2026;:ePub - PMID: 42129506 - PMCID: PMC13242704 - DOI: 10.1038/s41587-026-03115-2

Bolli E, Wirapati P, Hicham M, Xie Y, Siwicki M, Duval F, Goubet AG, Kiss M, Zitti B, Zwahlen T, Mcdowell S, Bill R, Angerani S, Engblom C, Anderson S, Jiang A, Hartley O, Sykes DB, Jankovic M, Fournier N, Gunzer M, Tarussio D, Tissot S, Sadow PM, Faquin WC, Sade-Feldman M, Weissleder R, Pai S, Mercier F, Manguso R, Pittet MJ

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth.
Cancer Cell. 2026;44(3):624-640.e12 - PMID: 41650972 - PMCID: PMC13179570 - DOI: 10.1016/j.ccell.2026.01.006

Rabinowitz Z, Deutsch-Williams RJ, Weissleder R

Erasable FAP Targeted Spray-On Probe for Fluorescence-Guided Surgery.
Adv Sci (Weinh). 2026;:e23986 - PMID: 41875349 - DOI: 10.1002/advs.202523986

Kim HS, Oh J, Jeon J, Fei F, Parvanian S, Kohler R, Garris C, Weissleder R

A ribonucleotide carbohydrate system (iRNC) enhances antigen presentation and controls glioblastoma.
Theranostics. 2026;16(8):3912-3927 - PMID: 41695470 - PMCID: PMC12905671 - DOI: 10.7150/thno.127558

Iqbal S, Hegde K, Arellano R, Uppot R, Zhao S, An T, Ellis H, Weissleder R

Percutaneous Endobiliary Radiofrequency Ablation (PERFA) for Unresectable Cholangiocarcinoma.
Acad Radiol. 2026;:ePub - PMID: 41832084 - DOI: 10.1016/j.acra.2026.02.034

Zong C, Lim K, Walker SA, Dai R, Jeong MH, George R, Jo JH, Iqbal S, Im H, Weissleder R

Do drugs with biliary toxicity cause cholangiocarcinoma?
bioRxiv. 2026;:ePub - PMID: 41959498 - PMCID: PMC13060385 - DOI: 10.64898/2026.03.31.715688
6 CSV HTML